Asked about that Thursday, Jerry Weir, a senior FDA vaccine officer, said his “gut feeling” was that a vaccine matched to a ...

The FDA has laid out a plan resembling the annual flu vaccine campaign, and the FDA's committee voted on one part of it. Here ...

The reformulated vaccine defends against new omicron strains, including XBB omicron variants. The panel stopped short of ...

The U.S. Food and Drug Administration's key science advisory panel, the Vaccines and Related Biological Products Advisory ...

The expert panel voted on Thursday to recommend replacing the primary Covid-19 vaccine series with the BA.4/5 bivalent shot.

STAT's @helenbranswell and @matthewherper are tracking today's meeting of the Food and Drug Administration’s Vaccines and ...

It's part of a plan to offer a single booster to the public each year that gives protection against the most recent, dominant ...

In a recent briefing document published by the United States Food and Drug Administration (US-FDA) ahead of an advisory ...

Future COVID-19 vaccines and boosters should be bivalent – meaning they’ll target older strains of the virus as well as the newer omicron BA.4 and BA.5 variants – following a unanimous recommendation ...

U.S. health officials will present a new vaccine plan that recommends an annual COVID-19 booster and proposes changes to the ...

The COVID recommendation was part of documents the Food and Drug Administration released Monday that discuss simplifying and ...

The FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) will meet Thursday to discuss how to simplify ...